Seeking Alpha
 

Vivus, Inc. (VVUS)

- NASDAQ
  • Spencer Osborne | Send Message 13 Apr

    Side Effects And Efficacy Of New Weight Loss Drugs $ARNA, $VVUS, $OREX http://seekingalpha.com/p/2bpbw
    Reply
      • Spencer Osborne | Send Message 13 Apr

        Vivus Sales Remain Flat - Stock Trend Not Good $VVUS http://seekingalpha.com/a/1tq46
        Reply
          • Spencer Osborne | Send Message 6 Apr

            Vivus: Qsymia Sales Dip In Weight Loss Season - Company Cutting Costs $VVUS http://seekingalpha.com/a/1tg5a
            Reply
              • Spencer Osborne | Send Message 31 Mar

                Vivus Offers Operational Update - Is Trouble Brewing? $VVUS http://seekingalpha.com/a/1t6za
                Reply
                  • Mike Zaman | Send Message 31 Mar

                    Biotech Momentum Indicators: Achaogen (AKAO), Novartis (NVS), VIVUS (VVUS) $AKAO, $NVS, $VVUS http://seekingalpha.com/p/2ay8w
                    Reply
                      • Spencer Osborne | Send Message 27 Mar

                        Has Orexigen Delivered A Death Knell To Vivus? $VVUS http://seekingalpha.com/a/1t0re
                        Reply
                          • Spencer Osborne | Send Message 23 Mar

                            Vivus: Qsymia Sales Slip, Company Needs To Shift Into Gear $VVUS http://seekingalpha.com/a/1sqds
                            Reply
                              • jonbaker22 | Send Message 21 Mar

                                $VVUS close above the 50 DMA, Their ED drug Stendra will Blow others away Green light Strong buy here.
                                Reply
                                  • StockConsultant | Send Message 16 Mar

                                    $VVUS stock nice bounce off support, a big "Stocks to Watch" mover along with $EW $INO $KNDI $SIGM today
                                    Reply
                                      Visit Seeking Alpha's
                                      VVUS vs. ETF Alternatives
                                      Company Description
                                      Vivus is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
                                      Sector: Healthcare
                                      Industry: Biotechnology
                                      Country: United States